Isoniazid
Isoniazid is a pharmaceutical drug with 90 clinical trials. Currently 9 active trials ongoing. Historical success rate of 85.5%.
Success Metrics
Based on 53 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
27
Mid Stage
30
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.5%
53 of 62 finished
14.5%
9 ended early
9
trials recruiting
90
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Shortened Regimen for Drug-susceptible TB in Children
Tuberculosis Clinical Trials Consortium Study 35
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
Clinical Trials (90)
Shortened Regimen for Drug-susceptible TB in Children
Tuberculosis Clinical Trials Consortium Study 35
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection
Re-evaluating the Duration in Children of TB Treatment
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
PanACEA - STEP2C -01
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 90